In the continuing evolution of personalized medicine, a new study has found evidence to support the value of a tool that measures the presence of cancer-derived molecules in the blood of patients with ...

Genetic and genomic testing guide breast cancer risk assessment and treatment, as discussed by Dr. Mark Robson at the Miami ...

It's time for researchers to reconsider the current paradigm of cancer as a genetic disease, argued Sui Huang from the Institute for Systems Biology ...

It's time for researchers to reconsider the current paradigm of cancer as a genetic disease, argues Sui Huang from the ...

In a recent essay, scientists challenge the prevailing genetic-focused model of cancer, advocating for a shift towards more ...

A Co Antrim woman is on a mission to raise awareness of lung cancer with a fundraising drive after her dad was recently ...

Dr. Alison Moody, a breast surgeon at Ascension Sacred Heart in Panama City, shares her advice on how to interpret the Jan. 3 ...

A research team led by Yang Gao from Rice University has made significant strides in understanding the molecular mechanisms of ADAR1, a protein that modulates ribonucleic acid (RNA) induced immune ...

A first-of-its-kind artificial intelligence (AI)-based neural network can rapidly analyze and interpret millions of cells from a patient sample, predicting molecular changes in the tissue.

During a Community Case Forum event in partnership with the Texas Society of Clinical Oncology, Natalie Vokes, MD, discussed trials of targeted agents for EGFR-mutant lung cancer.

A research team has uncovered new insights into the molecular mechanisms of ADAR1, a protein that regulates ribonucleic acid (RNA) induced immune responses. Their findings could open new pathways for ...

A rising number of Thais under 50 are being diagnosed with cancer, which a doctor says can be prevented by lifestyle changes ...